Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:27:40.172Z.
Calculation as of: 2026-10-06T15:27:40.172Z.
Quote observation: 2026-10-06T15:24:45.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7407100010b300fbb3ac755cbb3002365509bca003114ec09b48135e475ff23c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2003-12-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$11.30M
EV/FCF Ratio
N/A
TTM Avg
5.23x
3Y Avg
5.23x
5Y Avg
5.23x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | $10.93M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.94M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.81M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | N/A | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.17M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.20M | N/A | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.28M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.55M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | N/A | 5.23x | 5.23x | 5.23x |
| Satellos Bioscience Inc. (MSLE)vs › | $10.42M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2003-12-31 | 6.37x |
| 2003-12-30 | 6.37x |
| 2003-12-29 | 7.52x |
| 2003-12-26 | 8.28x |
| 2003-12-24 | 7.52x |
| 2003-12-23 | 7.52x |
| 2003-12-22 | 8.28x |
| 2003-12-19 | 10.95x |
| 2003-12-18 | 10.95x |
| 2003-12-17 | 10.95x |
| 2003-12-16 | 10.95x |
| 2003-12-15 | 10.18x |
| 2003-12-12 | 10.18x |
| 2003-12-11 | 10.18x |
| 2003-12-10 | 10.18x |
| 2003-12-09 | 10.18x |
| 2003-12-08 | 7.13x |
| 2003-12-05 | 6.37x |
| 2003-12-04 | 6.37x |
| 2003-12-03 | 4.85x |
| 2003-12-02 | 4.85x |
| 2003-12-01 | 4.85x |
| 2003-11-28 | 6.37x |
| 2003-11-26 | 6.37x |
| 2003-11-25 | 6.37x |
| 2003-11-24 | 6.37x |
| 2003-11-21 | 6.37x |
| 2003-11-20 | 6.37x |
| 2003-11-19 | 7.52x |
| 2003-11-18 | 7.52x |
| 2003-11-17 | 7.52x |
| 2003-11-14 | 7.52x |
| 2003-11-13 | 5.99x |
| 2003-11-12 | 5.99x |
| 2003-11-11 | 5.23x |
| 2003-11-10 | 5.23x |
| 2003-11-07 | 5.23x |
| 2003-11-06 | 5.23x |
| 2003-11-05 | 5.23x |
| 2003-11-04 | 5.23x |
| 2003-11-03 | 7.13x |
| 2003-10-31 | 6.75x |
| 2003-10-30 | 6.37x |
| 2003-10-29 | 6.37x |
| 2003-10-28 | 8.28x |
| 2003-10-27 | 10.18x |
| 2003-10-24 | 10.18x |
| 2003-10-23 | 9.80x |
| 2003-10-22 | 11.71x |
| 2003-10-21 | 11.71x |
| 2003-10-20 | 12.47x |
| 2003-10-17 | 12.47x |
| 2003-10-16 | 12.09x |
| 2003-10-15 | 12.09x |
| 2003-10-14 | 11.71x |
| 2003-10-13 | 12.09x |
| 2003-10-10 | 12.09x |
| 2003-10-09 | 12.09x |
| 2003-10-08 | 12.09x |
| 2003-10-07 | 12.09x |
| 2003-10-06 | 12.09x |
| 2003-10-03 | 12.09x |
| 2003-10-02 | 12.09x |
| 2003-10-01 | 12.09x |
| 2003-09-30 | 5.85x |
| 2003-09-29 | 6.23x |
| 2003-09-26 | 6.23x |
| 2003-09-25 | 6.04x |
| 2003-09-24 | 5.46x |
| 2003-09-23 | 5.46x |
| 2003-09-22 | 6.04x |
| 2003-09-19 | 4.11x |
| 2003-09-18 | 3.34x |
| 2003-09-17 | 3.34x |
| 2003-09-16 | 3.34x |
| 2003-09-15 | 3.34x |
| 2003-09-12 | 3.73x |
| 2003-09-11 | 3.73x |
| 2003-09-10 | 2.77x |
| 2003-09-09 | 2.77x |
| 2003-09-08 | 2.77x |
| 2003-09-05 | 2.77x |
| 2003-09-04 | 2.77x |
| 2003-09-03 | 3.73x |
| 2003-09-02 | 3.15x |
| 2003-08-29 | 3.15x |
| 2003-08-28 | 3.15x |
| 2003-08-27 | 3.15x |
| 2003-08-26 | 3.15x |
| 2003-08-25 | 3.15x |
| 2003-08-22 | 3.15x |
| 2003-08-21 | 2.96x |
| 2003-08-20 | 2.96x |
| 2003-08-19 | 2.57x |
| 2003-08-18 | 2.57x |
| 2003-08-15 | 2.57x |
| 2003-08-14 | 2.57x |
| 2003-08-13 | 2.57x |
| 2003-08-12 | 2.00x |
| 2003-08-11 | 2.00x |
| 2003-08-08 | 2.19x |
| 2003-08-07 | 2.19x |
| 2003-08-06 | 2.19x |
| 2003-08-05 | 2.19x |
| 2003-08-04 | 2.19x |
| 2003-08-01 | 2.19x |
| 2003-07-31 | 2.19x |
| 2003-07-30 | 2.38x |
| 2003-07-29 | 2.00x |
| 2003-07-28 | 2.00x |
| 2003-07-25 | 2.57x |
| 2003-07-24 | 2.00x |
| 2003-07-23 | 1.80x |
| 2003-07-22 | 1.80x |
| 2003-07-21 | 1.80x |
| 2003-07-18 | 2.00x |
| 2003-07-17 | 2.00x |
| 2003-07-16 | 2.00x |
| 2003-07-15 | 2.00x |
| 2003-07-14 | 1.80x |
| 2003-07-11 | 2.19x |
| 2003-07-10 | 2.19x |
| 2003-07-09 | 2.19x |
| 2003-07-08 | 2.57x |
| 2003-07-07 | 2.57x |
| 2003-07-03 | 2.57x |
| 2003-07-02 | 2.57x |
| 2003-07-01 | 3.34x |
